keyword
Keywords Immunohistochemistry for gastr...

Immunohistochemistry for gastrointestinal neoplasms

https://read.qxmd.com/read/38442781/pulmonary-gangliocytic-paraganglioma-an-under-recognized-mimic-of-carcinoid-tumor
#21
JOURNAL ARTICLE
Julia R Naso, Diping Wang, Arthur O Romero, Timothy Leclair, Peter Smit, Jennifer M Boland, Andrew L Folpe, Melanie C Bois
Gangliocytic paragangliomas are rare neoplasms occurring almost exclusively in the ampullary region of the gastrointestinal tract. Although these tumors are not typically considered in the differential diagnosis of primary pulmonary neoplasia, 5 cases of primary pulmonary gangliocytic paragangliomas have been previously reported. Herein we report our experience with 3 additional examples, all referred to our Anatomic Pathology Consultation service. The patients (a 32-year-old man, a 69-year-old woman and a 55-year-old man) each presented with an endobronchial (2 cases) or upper lobe lung mass, ranging from 1...
March 3, 2024: Human Pathology
https://read.qxmd.com/read/38425403/prohibitin-1-inhibits-cell-proliferation-and-induces-apoptosis-via-the-p53-mediated-mitochondrial-pathway-in-vitro
#22
JOURNAL ARTICLE
Juan-Juan Shi, Yi-Kai Wang, Mu-Qi Wang, Jiang Deng, Ning Gao, Mei Li, Ya-Ping Li, Xin Zhang, Xiao-Li Jia, Xiong-Tao Liu, Shuang-Suo Dang, Wen-Jun Wang
BACKGROUND: Prohibitin 1 (PHB1) has been identified as an antiproliferative protein that is highly conserved and ubiquitously expressed, and it participates in a variety of essential cellular functions, including apoptosis, cell cycle regulation, proliferation, and survival. Emerging evidence indicates that PHB1 may play an important role in the progression of hepatocellular carcinoma (HCC). However, the role of PHB1 in HCC is controversial. AIM: To investigate the effects of PHB1 on the proliferation and apoptosis of human HCC cells and the relevant mechanisms in vitro ...
February 15, 2024: World Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/38416360/hand2-immunohistochemistry-in-the-diagnosis-of-paragangliomas-and-other-neuroendocrine-neoplasms
#23
JOURNAL ARTICLE
Jiri Soukup, Monika Manethova, Vaclav Stejskal, Marie Novakova, Jaroslava Duskova, Helena Hornychova, Maria Hacova, Iva Staniczkova-Zambo, Tomas Zelinka, Mikulas Kosak, Tomas Cesak, David Netuka, Ales Ryska, Filip Gabalec
Hand2 is a core transcription factor responsible for chromaffin cell differentiation. However, its potential utility in surgical pathology has not been studied. Thus, we aimed to investigate its expression in paragangliomas, other neuroendocrine neoplasms (NENs), and additional non-neuroendocrine tumors. We calibrated Hand2 immunohistochemistry on adrenal medulla cells and analyzed H-scores in 46 paragangliomas (PGs), 9 metastatic PGs, 21 cauda equina neuroendocrine tumors (CENETs), 48 neuroendocrine carcinomas (NECs), 8 olfactory neuroblastomas (ONBs), 110 well-differentiated NETs (WDNETs), 10 adrenal cortical carcinomas, 29 adrenal cortical adenomas, 8 melanomas, 41 different carcinomas, and 10 gastrointestinal stromal tumors (GISTs)...
February 28, 2024: Endocrine Pathology
https://read.qxmd.com/read/38406594/pathological-features-of-gastric%C3%A2-type-endocervical-adenocarcinoma-a-report-of-two-cases
#24
Jiahui Zhou, Xiangning Zhang, Weibo Mao, Yiling Zhu, Liping Yan, Jiangle Jiang, Min Zhang
Gastric-type endocervical adenocarcinoma (GEA) is an uncommon form of uterine cervical adenocarcinoma with an unfavorable prognosis. The tumor consists of glands exhibiting a morphological resemblance to gastric cells and occasionally manifests features akin to pancreaticobiliary mucinous adenocarcinoma. GEA differs from the typical cervical cancer, particularly in its lack of association with the human papillomavirus. Immunophenotypic analysis suggests intestinal differentiation. The present study reports two cases of GEA occurring in postmenopausal individuals who were diagnosed in Lishui Central Hospital (Lishui, China) between January 2015 and January 2023...
April 2024: Oncology Letters
https://read.qxmd.com/read/38396207/gastrointestinal-stromal-tumors-in-fine-needle-aspiration-biopsies
#25
JOURNAL ARTICLE
Seyedreza Mousavi, Yuho Ono, Paul A VanderLaan, Yaileen D Guzmán-Arocho
Gastrointestinal stromal tumors (GISTs), although rare, are the most common mesenchymal neoplasms of the gastrointestinal tract. Their potential for malignancy underscores the significance of identifying them through cytomorphologic findings and pertinent immunohistochemical markers. GISTs can emerge anywhere along the gastrointestinal tract with a predilection for the stomach. The clinical manifestations vary from nonspecific abdominal symptoms to incidental discovery during diagnostic interventions for unrelated signs and symptoms...
February 23, 2024: Diagnostic Cytopathology
https://read.qxmd.com/read/38336371/multiomic-molecular-characterization-of-the-response-to-combination-immunotherapy-in-mss-pmmr-metastatic-colorectal-cancer
#26
JOURNAL ARTICLE
Shogo Takei, Yosuke Tanaka, Yi-Tzu Lin, Shohei Koyama, Shota Fukuoka, Hiroki Hara, Yoshiaki Nakamura, Yasutoshi Kuboki, Daisuke Kotani, Takashi Kojima, Hideaki Bando, Saori Mishima, Toshihide Ueno, Shinya Kojima, Masashi Wakabayashi, Naoya Sakamoto, Motohiro Kojima, Takeshi Kuwata, Takayuki Yoshino, Hiroyoshi Nishikawa, Hiroyuki Mano, Itaru Endo, Kohei Shitara, Akihito Kawazoe
BACKGROUND: Immune checkpoint inhibitor (ICI) combinations represent an emerging treatment strategies in cancer. However, their efficacy in microsatellite stable (MSS) or mismatch repair-proficient (pMMR) colorectal cancer (CRC) is variable. Here, a multiomic characterization was performed to identify predictive biomarkers associated with patient response to ICI combinations in MSS/pMMR CRC for the further development of ICI combinations. METHODS: Whole-exome sequencing, RNA sequencing, and multiplex fluorescence immunohistochemistry of tumors from patients with MSS/pMMR CRC, who received regorafenib plus nivolumab (REGONIVO) or TAS-116 plus nivolumab (TASNIVO) in clinical trials were conducted...
February 8, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38292849/comprehensive-evaluation-of-rare-case-from-diagnosis-to-treatment-of-a-sigmoid-schwannoma-a-case-report
#27
Jing-Yi Li, Xi-Zhuang Gao, Jian Zhang, Xiang-Zheng Meng, Yi-Xian Cao, Kun Zhao
BACKGROUND: Schwannomas are uncommon tumors originating from Schwann cells, forming the neural sheath. They account for approximately 2%-6% of all mesenchymal tumors and are most commonly identified in peripheral nerve trunks, with rarity in the gastrointestinal tract. Among gastrointestinal locations, the stomach harbors the majority of nerve sheath tumors, while such occurrences in the sigmoid colon are exceptionally infrequent. CASE SUMMARY: This study presented a clinical case involving a 60-year-old female patient who, during colonoscopy, was diagnosed with a submucosal lesion that was later identified as a nerve sheath tumor...
January 15, 2024: World Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/38279752/large-b-cell-lymphoma-with-irf4-rearrangement-in-the-nasolacrimal-duct-a-clinicopathological-study-of-one-case-and-literature-review
#28
Wang-Xing Chen, Jun Wu, Jian-Guo He
BACKGROUND: Large B-cell lymphoma (LBCL) with interferon regulatory factor 4 (IRF4) rearrangement (LBCL-IRF4) is a rare subtype of LBCL, with a high prevalence in Waldeyer's ring as well as the neck, head and gastrointestinal lymph nodes. MATERIALS AND METHODS: A patient with 2-month clinical symptoms of nasal obstruction and facial swelling was reported in this short review. A nasal endoscopy examination revealed a neoplasm in the inferior nasal meatus. Both CT and enhanced MRI showed that a soft tissue occupied the nasolacrimal duct, with bone destruction, and extended into the left nasal cavity and left lacrimal gland area...
January 25, 2024: Current Molecular Medicine
https://read.qxmd.com/read/38212892/n-cadherin-a-diagnostic-marker-to-help-discriminate-primary-liver-carcinomas-from-extrahepatic-carcinomas
#29
JOURNAL ARTICLE
Tiemo S Gerber, Dirk A Ridder, Benjamin Goeppert, Alexander Brobeil, Philipp Stenzel, Stefanie Zimmer, Jörg Jäkel, Marie Oliver Metzig, Roxana Schwab, Steve Z Martin, András Kiss, Frank Bergmann, Peter Schirmacher, Peter R Galle, Hauke Lang, Wilfried Roth, Beate K Straub
Distinguishing primary liver cancer (PLC), namely hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA), from liver metastases is of crucial clinical importance. Histopathology remains the gold standard, but differential diagnosis may be challenging. While absent in most epithelial, the expression of the adherens junction glycoprotein N-cadherin is commonly restricted to neural and mesenchymal cells, or carcinoma cells that undergo the phenomenon of epithelial-to-mesenchymal transition (EMT)...
January 11, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38196518/-actb-may-serve-as-a-predictive-marker-for-the-efficacy-of-lenvatinib-in-patients-with-hbv-related-early-stage-hepatocellular-carcinoma-following-partial-hepatectomy-a-retrospective-cohort-study
#30
JOURNAL ARTICLE
Wei Dong, Minghao Zou, Jie Sheng, Wenxuan Zhou, Yizhou Wang, Yuchan Zhang, Jutang Li, Youwen Qian, Hua Yu, Tao Lu, Jianqiang Pan, Yuyao Zhu, Shuping Qu, Zhao Yang, Qingyuan Lin, Linghao Zhao, Wenming Cong, Bo Xu, Chengjing Zhang, Hui Liu, Hui Dong
BACKGROUND: The lack of effective biomarkers for the treatment of postoperative recurrence in hepatocellular carcinoma (HCC) persists despite lenvatinib therapy. This study aims to identify beta-actin ( ACTB ) as a predictive biomarker for lenvatinib that can facilitate individualized treatment for HCC. METHODS: This retrospective study included a subset of patients with HCC who underwent partial hepatectomy, with some receiving postoperative lenvatinib treatment and others not receiving lenvatinib treatment...
December 31, 2023: Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/38192656/non%C3%A2-synchronous-bilateral-metastatic-ovarian-cancer-originating-from-small-bowel-adenocarcinoma-with-multidisciplinary-treatment-a-case-report
#31
Xingting He, Shuang Chen, Yejiang Zhou, Alexander Tobias Teichmann, Shugui Ding, Juan Fan, Xiuli Xiao, Dongmei Zhao, Liang Cai, Yifan Jiang, Xuemei Deng, Hongru Yang
Primary small bowel adenocarcinoma (SBA) is a rare gastrointestinal cancer with a low incidence of ovarian metastasis. Differential diagnosis of metastatic and primary ovarian cancer is often challenging. The present study reported the case of a 45-year-old woman with jejunal adenocarcinoma who presented with right ovarian, left ovarian, abdominopelvic implant and local recurrent bowel wall metastases successively after primary tumor resection. The ovarian masses of the patient originated from SBA, which was confirmed by immunohistochemical results...
February 2024: Oncology Letters
https://read.qxmd.com/read/38182686/trim21-usp15-balances-acsl4-stability-and-the-imatinib-resistance-of-gastrointestinal-stromal-tumors
#32
JOURNAL ARTICLE
Zhiwei Cui, Haoyu Sun, Zhishuang Gao, Chao Li, Tingting Xiao, Yibo Bian, Zonghang Liu, Tianhao Gu, Jianan Zhang, Tengyun Li, Qianzheng Zhou, Zhongyuan He, Bowen Li, Fengyuan Li, Zekuan Xu, Hao Xu
BACKGROUND: Imatinib has become an exceptionally effective targeted drug for treating gastrointestinal stromal tumors (GISTs). Despite its efficacy, the resistance to imatinib is common in GIST patients, posing a significant challenge to the effective treatment. METHODS: The expression profiling of TRIM21, USP15, and ACSL4 in GIST patients was evaluated using Western blot and immunohistochemistry. To silence gene expression, shRNA was utilized. Biological function of TRIM21, USP15, and ACSL4 was examined through various methods, including resistance index calculation, colony formation, shRNA interference, and xenograft mouse model...
January 5, 2024: British Journal of Cancer
https://read.qxmd.com/read/38175383/pole-mutant-colon-adenocarcinoma-case-presentation-and-histopathological-evaluation
#33
JOURNAL ARTICLE
Tamás Pancsa, Béla Vasas, Zsombor Melegh, Erika Tóth, László Torday, Anita Sejben
INTRODUCTION: POLE mutant phenotype in colon adenocarcinomas represents a rare molecular subtype. These tumours are generally responsive to immune-checkpoint inhibition therapy and, therefore, are currently considered as a subtype with good prognosis. We hereby present the first detailed case presentation of a POLE mutant colon adenocarcinoma with useful microscopic features. CASE REPORT: A 53-year-old male patient's colon adenocarcinoma histologically showed wide variety of growth patterns and massive intra- and peritumoural lymphocytic infiltrate...
January 4, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38173438/transient-receptor-potential-related-risk-model-predicts-prognosis-of-hepatocellular-carcinoma-patients
#34
JOURNAL ARTICLE
Xiao-Cai Mei, Qian Chen, Shi Zuo
BACKGROUND: Members of the transient receptor potential (TRP) protein family shape oncogenic development, but the specific relevance of TRP-related genes in hepatocellular carcinoma (HCC) has yet to be defined. AIM: To investigate the role of TRP genes in HCC, their association with HCC development and treatment was examined. METHODS: HCC patient gene expression and clinical data were downloaded from The Cancer Genome Atlas database, and univariate and least absolute shrinkage and selection operator Cox regression models were employed to explore the TRP-related risk spectrum...
December 15, 2023: World Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/38161645/primary-hepatic-functional-neuroendocrine-tumor-in-an-elderly-female-case-report
#35
Naveen Kumar Kushwaha, Pradeep Jaiswal, Prashant Gupta, Niharika Mishra, Shrirang Vasant Kulkarni
KEY CLINICAL MESSAGE: Primary hepatic neuroendocrine tumor, an exceptionally rare subtype, poses a diagnostic challenge. Oncological resections should be considered, even in elderly patients after following protocolized pre-operative optimizations. ABSTRACT: Neuroendocrine tumors (NETs) are rare tumors that primarily develop in the gastrointestinal and respiratory tracts. While the liver is commonly affected by NET metastases, primary hepatic neuroendocrine tumors (PHNETs) are an exceptionally rare subtype...
January 2024: Clinical Case Reports
https://read.qxmd.com/read/38159337/zotiraciclib-tg02-for-newly-diagnosed-glioblastoma-in-the-elderly-or-for-recurrent-glioblastoma-the-eortc-1608-steam-trial
#36
JOURNAL ARTICLE
Emilie Le Rhun, Thierry Gorlia, Jörg Felsberg, Joost Jongen, Claude-Alain Maurage, François Ducray, Dorothee Gramatzki, Peter Hau, Olivier L Chinot, Matthias Preusser, Stephanie Cartalat, Patrick Roth, Martin van den Bent, Julia Furtner, Maike Collienne, Guido Reifenberger, Michael Weller
BACKGROUND: Zotiraciclib (TG02) is an oral multi-cyclin dependent kinase (CDK) inhibitor thought to inhibit tumor growth via CDK-9-dependent depletion of survival proteins such as c-MYC and MCL-1 which are frequently overexpressed in glioblastoma. METHODS: EORTC 1608 (NCT03224104) (STEAM) had a three parallel group (A,B,C) phase Ib, open-label, non-randomized, multicenter design in IDH wild-type newly diagnosed glioblastoma or anaplastic astrocytoma. Groups A and B explored the maximum tolerated dose (MTD) of TG02 in elderly patients, in combination with hypofractionated radiotherapy alone (group A) or temozolomide alone (group B), according to O6 -methylguanine DNA methyltransferase promoter methylation status determined centrally...
December 18, 2023: European Journal of Cancer
https://read.qxmd.com/read/38136318/ampullary-adenocarcinoma-a-review-of-the-mutational-landscape-and-implications-for-treatment
#37
REVIEW
Vasileios Tsagkalidis, Russell C Langan, Brett L Ecker
Ampullary carcinomas represent less than 1% of all gastrointestinal malignancies with an incidence of approximately 6 cases per 1 million. Histologic examination and immunohistochemistry have been traditionally used to categorize ampullary tumors into intestinal, pancreatobiliary or mixed subtypes. Intestinal-subtype tumors may exhibit improved survival versus the pancreatobiliary subtype, although studies on the prognostic value of immunomorphologic classification have been inconsistent. Genomic classifiers hold the promise of greater reliability, while providing potential targets for precision oncology...
December 9, 2023: Cancers
https://read.qxmd.com/read/38129820/lum-as-a-novel-prognostic-marker-and-its-correlation-with-immune-infiltration-in-gastric-cancer-a-study-based-on-immunohistochemical-analysis-and-bioinformatics
#38
JOURNAL ARTICLE
Wu Xu, Shasha Chen, Qiuju Jiang, Jinlan He, Feifei Zhang, Zhuying Wang, Caishun Ruan, Bin Shi
BACKGROUND: Gastric cancer (GC) is considered the sixth highly prevailing malignant neoplasm and is ranked third in terms of cancer mortality rates. To enable an early and efficient diagnosis of GC, it is important to detect the fundamental processes involved in the oncogenesis and progression of gastric malignancy. The understanding of molecular signaling pathways can facilitate the development of more effective therapeutic strategies for GC patients. METHODS: The screening of genes that exhibited differential expression in early and advanced GC was performed utilizing the Gene Expression Omnibus databases (GSE3438)...
December 21, 2023: BMC Gastroenterology
https://read.qxmd.com/read/38107763/epithelioid-subtype-gastrointestinal-stromal-tumors-of-stomach-in-an-endoscopic-biopsy-a-potential-diagnostic-pitfall
#39
Wenfeng Xu, Hao Tang, Ying Chen, Jiashuang Wang, Zhongjiao Chen, Yujuan Xu, Deyu Guo
BACKGROUND: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract with a broad morphological spectrum. Although epithelioid GISTs account for 20% of GISTs, their morphological features may pose a diagnostic pitfall for pathologists due to their morphological similarities to poorly differentiated adenocarcinoma and lymphoma. CASE PRESENTATION: Herein, we report a 65-year-old male patient with gastric epithelioid GIST misdiagnosed as adenocarcinoma for four years...
2023: OncoTargets and Therapy
https://read.qxmd.com/read/38102915/primary-neuroendocrine-carcinoma-of-cervical-lymph-node-masquerading-as-non-hodgkin-lymphoma-a-diagnostic-challenge
#40
JOURNAL ARTICLE
Anurag Singh, Rashmi Kushwaha, Pragati Chauhan, Gulshan Kumar
A large extended family of tumors classified as neuroendocrine tumors most commonly occurs in the gastrointestinal tract and bronchus pulmonary tree. It is extremely unusual for a primary neuroendocrine tumor to present as a cervical lymph node mass at initial presentation. We discuss the rare case of a 55-year-old man who initially complained of a right neck mass that was misinterpreted as non-Hodgkin lymphoma on fine needle aspiration cytology. By integrating clinical findings, radiography, fine-needle aspiration cytology, histomorphology, and immunohistochemistry analysis, a definitive diagnosis of primary neuroendocrine carcinoma of the cervical lymph node was made...
December 15, 2023: Journal of Cancer Research and Therapeutics
keyword
keyword
82724
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.